Abstract: The present invention relates to a composition comprising a Ttyh1 gene expression inhibitor or a Ttyh1 protein activity inhibitor, and a method of preventing or treating Alzheimer's disease using the same.

Abstract: The present invention relates to a composition comprising a Ttyh1 gene expression inhibitor or a Ttyh1 protein activity inhibitor, and a method of preventing or treating Alzheimer's disease using the same.

Abstract: Provided is a pharmaceutical composition for inhibiting human cytomegalovirus (HCMV) replication by increasing the expression of a target gene of a notch signaling pathway, for example, hairy and enhancer of split-1 (Hes1), hairy and enhancer of split-5 (Hes5), hairy/enhancer-of-split related with YRPW motif protein 1 (Hey1) and hairy/enhancer-of-split related with YRPW motif protein 2 (Hey2), and a method and use for treating an HCMV infectious disease using the same. The composition of the present invention has an excellent effect in inhibiting the HCMV replication, and therefore a target and a therapeutic agent for preventing or treating various HCMV-related diseases caused by the HCMV infection and a use for treating the HCMV infectious disease may be provided.

Abstract: A method of preventing or treating glioma by inhibiting expression of Tarbp2, which is a novel transcription factor inducing Notch signal activation, and a pharmaceutical composition for treating glioma using shRNA or siRNA as a Tarbp2 expression inhibitor, as well as a method of treating glioma using the same and use thereof, are provided.

Abstract: Provided is a novel pharmaceutical composition for inhibiting human cytomegalovirus (HCMV) replication by increasing the expression of a target gene of a notch signaling pathway, for example, hairy and enhancer of split-1 (Hes1), hairy and enhancer of split-5 (Hes5), hairy/enhancer-of-split related with YRPW motif protein 1 (Hey1) and hairy/enhancer-of-split related with YRPW motif protein 2 (Hey2), and a method and use for treating an HCMV infectious disease using the same. The novel composition of the present invention has an excellent effect in inhibiting the HCMV replication, and therefore a novel target and a therapeutic agent for preventing or treating various HCMV-related diseases caused by the HCMV infection and a novel use for treating the HCMV infectious disease may be provided.

Abstract: A pharmaceutical composition and a method for treating glioma are provided. The pharmaceutical composition for preventing or treating glioma includes a Tar RNA binding protein 2 (Tarbp2) protein or gene encoding the same as an active component. The method for treating glioma includes administering to a subject in need thereof a pharmaceutically effective amount of aTar RNA binding protein 2 (Tarbp2) protein or gene encoding the same.

Abstract: A method of preventing or treating glioma by inhibiting expression of Tarbp2, which is a novel transcription factor inducing Notch signal activation, and a pharmaceutical composition for treating glioma using shRNA or siRNA as a Tarbp2 expression inhibitor, as well as a method of treating glioma using the same and use thereof, are provided.

Abstract: The present invention relates to an audio control device using a multi-screen. The audio control device has a touch screen on which a bass axis and a treble axis for the sound of audio equipment are displayed in a multidimensional fashion, and on which a point selected by a user for audio control is inputted. An audio control section collectively calculates a bass value and a treble value corresponding to the point selected for audio control. A control section controls a speaker based on a result calculated by the audio control section.